The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Chitosan Polysaccharides for Osteoporosis Therapy in Postmenopausal Women
|
|
Author(s): Youssef Ait Hamdan (Cadi Ayyad University, Morocco), Imade Armadi (Cadi Ayyad University, Morocco), Saloua Mabsor-Zgandaoui (Ibn Tofail University, Morocco), Fatima Ezzahra Elamrani (Cadi Ayyad University, Morocco), khawla Rachmoune (Cadi Ayyad University, Morocco), Adil El Housseini (AQUAMAR Laboratory, Faculty of Sciences, Ibn Zohr University, Morocco), Meriem Mekouar (Faculté de Médecine et de Pharmacie de Rabat, Morocco), Amina El Kaoui (Moulay Ismail University, Meknes, Morocco), Maysae Chehber (Cadi Ayyad University, Morocco), Priscilla Barbosa Sales de Albuquerque (University of Pernambuco, Brazil), Anass Belbachir (Laboratory of Innovations in Biotechnology, Pharmaceutical Bioengineering, and Artificial Intelligence, Morocco)and Mohammed Rhazi (Cadi Ayyad University, Morocco)
Copyright: 2026
Pages: 38
Source title:
Biomedical Applications and Toxicity of Polymers, Nanoparticles, Biomaterials, and Metal Ions
Source Author(s)/Editor(s): Deniz Eren Erişen (Institute of Semiconductors, Guangdong Academy of Sciences, China), Faez Iqbal Khan (Xi’an Jiaotong-Liverpool University, China), Cheng Chang (Institute of New Materials, Guangdong Academy of Sciences, China & University of Birmingham, UK)and Kai-Cheng Yan (University of Bath, UK)
DOI: 10.4018/979-8-3373-0055-9.ch011
Purchase
|
Abstract
Osteoporosis is a common degenerative disease in postmenopausal women, characterized by a loss of bone density and skeletal fragility, increasing fracture risk. This chapter examines the use of chitosan, a natural biopolymer derived from chitin, as a therapeutic agent in osteoporosis treatment. Chitosan's unique properties, such as biocompatibility, biodegradability, and the ability to form three-dimensional structures, make it a promising candidate for bone therapies. The chapter also analyzes chemical and functional modifications to chitosan that enhance its bioactive effects and drug delivery capabilities, offering promising perspectives for non-hormonal osteoporosis treatments.
Related Content
|
Saloua Mabsor-Zgandaoui, Khawla Rachmoune, Ilham Aftais, Fatima Ezzahra Elamrani, Imade Amradi, Adil El Housseini, Youssef Ait Hamdan, Youness Zgandaoui, Abdelghani Iddar, Mohammed El Mzibri, Adnane Moutaouakkil, Aboubaker El Hessni, Abdelhalim Mesfioui.
© 2026.
30 pages.
|
|
Yusuf Olatunji Waidi.
© 2026.
20 pages.
|
|
Ajinkya Nene, Sorour Sadeghzade, Wenjie Yang, Prakash Somani.
© 2026.
12 pages.
|
|
Seyyed Mohammad Amin Mousavi-Sagharchi, Mahdieh Ranjbar-Jamalabadi, Sama Yavari, Elina Afrazeh, Naresh Poondla, Mohsen Sheykhhasan.
© 2026.
32 pages.
|
|
Wenqiang Xie, Yuan Su, Ruiqi Zhang, Sijia Li, Jia Ni, Longquan Shao.
© 2026.
18 pages.
|
|
Zhengao Wang, Huiyu Zhao, Yao Han, Wuyi Zhou, Chengyun Ning.
© 2026.
30 pages.
|
|
Navya Aggarwal, Shinjini Sen, Tanmay J. Urs, Shreya Gupta, Banashree Bondhopadhyay.
© 2026.
36 pages.
|
|
|